Yahoo! Finance: Top Stories

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Jun 26, 2025 - 18:06
 0
Vor Bio back from brink with autoimmune drug deal rising to $4bn
Read More

Tags:

Previous Article

Here’s what’s taking the S&P 500 so long to return to an all-time high

Next Article

Why used-car dealer Carvana is pushing real-time billing

Related Posts

Argus Sees Union Pacific (UNP) As A Compelling Opportunity

Argus Sees Union Pacific (UNP) As A Compelling Opportunity

May 21, 2025  0

Stocks to Watch Wednesday: Target, Wolfspeed, Lowe's

Stocks to Watch Wednesday: Target, Wolfspeed, Lowe's

May 21, 2025  0

Why Is Biohaven Stock Falling On Thursday?

Why Is Biohaven Stock Falling On Thursday?

May 15, 2025  0